TTR Y78F

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTTR Y78F
Drug Alias Nameimmunotherapy (Porto)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsTransthyretin inhibitors
TargetsTransthyretinBeta amyloid A4 protein
Therapy Area/IndicationsAmyloid Neuropathies, Familial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversidade do Porto
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversidade do Porto
Active IndicationsN/A
Inactive IndicationsAmyloid Neuropathies, Familial

Other Information

ATC CodeN/A
Related LinksN/A